Jorma Tapio Routti

Suomen Itsenäisyyden Juhlarahasto is a Finnish innovation fund directly under the Finnish parliament. It primarily invests in foreign and national funds while making selected follow-up investments in Finnish start-ups and later-stage companies. It can consider investing in foreign companies if it is purposeful for the fund's goals. Its investment focus is in the well-being of the Finnish people, environment, and the economy. The size of its initial venture is up to EUR 2 million and its average investment period per company is from 4 to 10 years.

Fibrogen Europe Oy develops and markets recombinant human collagens and gelatins for research purposes. It serves companies in the pharmaceutical, vaccine, medical device, diagnostic, industrial, food, cosmetic, and nutraceutical businesses. The company was founded on May 22, 1996 and is located at Helsinki, Finland.

Fibrogen Europe Oy develops and markets recombinant human collagens and gelatins for research purposes. It serves companies in the pharmaceutical, vaccine, medical device, diagnostic, industrial, food, cosmetic, and nutraceutical businesses. The company was founded on May 22, 1996 and is located at Helsinki, Finland.